BiotechTube
Home/Radiomer Therapeutics/Philip Breitfeld, MD
PB

Philip Breitfeld, MD

Chief Medical Officer

Radiomer Therapeutics

Therapeutic Areas

Oncology

Radiomer Therapeutics Pipeline

DrugIndicationPhase
Lead Program (undisclosed)OncologyPre-clinical

Leadership Team at Radiomer Therapeutics

AV
Atul Varadhachary, MD, PhD
Chief Executive Officer
MW
Mark Worscheh, MBA
Chief Financial Officer
MJ
Michael J. Heffernan, PhD, PE
Vice President of Operations
SD
Sougata Dey, PhD
Director of Chemistry
View full Radiomer Therapeutics profile